Related Experiment Video
Updated: Aug 27, 2025
08:07
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.7K
Bacterial outer membrane vesicles as a candidate tumor vaccine platform
Shuming Wang1, Jiayi Guo1, Yang Bai1
1State Key Laboratory of Reproductive Regulation & Breeding of Grassland Livestock, School of Life Science, Inner Mongolia University, Hohhot, China.
Frontiers in Immunology
|September 26, 2022
Summary
Bacterial outer membrane vesicles (OMVs) show promise as novel cancer vaccines. These vesicles can present tumor antigens and are being investigated in clinical trials for cancer therapy.
Area of Science:
- Biotechnology
- Immunology
- Oncology
Background:
- Cancer poses significant health challenges, necessitating novel therapeutic strategies beyond conventional treatments.
- Drug resistance and tumor metastasis highlight the need for innovative approaches in cancer care.
Purpose of the Study:
- To review bacterial outer membrane vesicles (OMVs) and their potential applications in cancer vaccines.
- To explore the interaction of OMVs with host cells for therapeutic development.
Main Methods:
- Review of existing literature on bacterial outer membrane vesicles (OMVs).
- Analysis of OMV composition, immunogenic properties, and interaction with host cells.
- Examination of OMV-based vaccine development for cancer treatment.
Main Results:
- Bacterial outer membrane vesicles (OMVs) possess immunogenic components suitable for vaccine development.
- OMVs can be engineered to present tumor antigens or deliver therapeutic agents.
- Several OMV-based vaccines are approved for other diseases, with cancer applications in clinical trials.
Conclusions:
- Bacterial outer membrane vesicles (OMVs) represent a promising platform for developing new cancer vaccines.
- OMVs offer a versatile approach for cancer immunotherapy and targeted drug delivery.
- Further research into OMV-host interactions can optimize their therapeutic efficacy in oncology.
Related Concept Videos
01:30Cancer Vaccines
493
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
493
01:27Tumor Immunotherapy
643
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
643
01:29Microorganisms in Medicine and Therapeutics
207
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
207